The CBSA is launching its 2011 Symposium Series Thursday, February 17, with the session, "Biotech & Pharma," 1-7 p.m., at the Grand Hyatt Denver, 1750 Welton Street. The announcement is made by Holli Baumunk, CBSA President & CEO, who says "We're extremely fortunate to welcome four Colorado company CEOs as presenters at our first quarter Biotech & Pharma Symposium." Participating CEOs include: Robert M. Di Scipio, President and CEO, Aegis Analytical Corp.; Bob Conway, President and CEO, Array BioPharma; Tim Rodell, President and CEO, GlobeImmune; and Steve Orndorff, President and CEO, Ariel Pharmaceuticals. Other companies and organizations on the agenda include: the Colorado Initiative in Molecular Biotechnology, Pfizer, Amgen and Genentech.
"Information covered in Thursday's session will include: how health care reform will impact Colorado companies; how companies can prepare for health care reform, including biosimilars, Independent Payment Advisory Board, comparative effectiveness and tax increases; controlling costs and minimizing risks in the manufacturing and drug development process; and lessons Colorado companies have learned in the drug development process," Baumunk explains.
Link to the Business Wire release